立方制药 (003020.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(立方制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,125,115,398.63769,332,113.02333,618,253.501,900,789,181.921,524,501,653.001,267,790,879.76811,816,818.00
 营业收入(元) 1,125,115,398.63769,332,113.02333,618,253.501,900,789,181.921,524,501,653.001,267,790,879.76811,816,818.00
二、营业总成本(元) 1,000,958,904.88682,320,390.82307,762,871.441,682,608,293.101,357,619,917.081,134,992,117.80730,374,001.92
 营业成本(元) 338,419,569.21219,061,736.70103,396,947.09922,201,876.52815,399,383.49721,723,165.67515,196,866.06
 研发费用(元) 53,806,835.6836,733,959.7523,546,764.4784,955,600.2059,933,416.4542,799,903.6912,539,427.60
 营业税金及附加(元) 16,659,556.8411,671,815.734,804,848.6018,335,254.8112,800,392.599,983,592.175,661,811.78
 销售费用(元) 528,538,993.22370,541,100.39158,408,834.30598,452,170.05426,697,055.82331,810,137.82183,366,298.26
 管理费用(元) 63,906,891.9544,822,686.1418,046,458.5961,957,320.4346,562,333.1731,073,547.1715,164,043.13
 财务费用(元) -372,942.02-510,907.89-440,981.61-3,293,928.91-3,772,664.44-2,398,228.72-1,554,444.91
  其中:利息费用(元) 926,622.88832,408.32230,375.001,281,276.05532,670.691,245,078.23111,613.92
  其中:利息收入(元) 1,666,307.901,369,710.82855,219.774,650,814.354,386,501.133,696,303.551,557,113.87
三、其他经营收益
 加:公允价值变动收益(元) 1,247,272.111,458,354.11972,789.60315,515.082,388,524.441,380,091.84-3,860.64
 加:投资收益(元) 9,025,245.565,267,272.343,433,225.3927,485,243.7427,502,965.8319,793,055.44-365,672.63
  其中:对联营企业和合营企业的投资收益(元) --1,939,856.661,058,661.41---662,672.63
 资产处置收益(元) 92,974.4696,401.57----3,823.43-1,358.92
 资产减值损失(元) -9,054,141.15-9,553,286.58-2,070,274.62-9,201,004.38-5,499,770.47-3,155,525.52-2,412,527.26
 信用减值损失(元) -1,971,133.30-2,130,947.86-790,341.67-2,105,265.78-3,851,895.10-5,764,914.98-1,578,521.58
 其他收益(元) 8,066,987.995,046,061.761,614,338.3320,594,831.903,909,811.881,972,543.64843,372.06
四、营业利润(元) 131,563,699.4287,195,577.5429,015,119.09255,270,209.38191,331,372.50147,020,188.9577,924,247.11
 加:营业外收入(元) 456,195.12395,084.24237,277.213,145,360.29254,037.33190,688.06111,158.88
 减:营业外支出(元) 699,739.71647,455.13244,053.46998,827.95678,004.79561,612.73948.74
五、利润总额(元) 131,320,154.8386,943,206.6529,008,342.84257,416,741.72190,907,405.04146,649,264.2878,034,457.25
 减:所得税费用(元) 15,663,621.3510,950,599.241,552,821.3923,534,161.9718,076,720.3615,520,014.1811,892,777.23
六、净利润(元) 115,656,533.4875,992,607.4127,455,521.45233,882,579.75172,830,684.68131,129,250.1066,141,680.02
(一)按经营持续性分类
  持续经营净利润(元) 115,656,533.4875,992,607.4127,455,521.45233,882,579.75172,830,684.68131,129,250.1066,141,680.02
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 118,979,752.4577,430,915.0930,372,220.01226,672,720.79171,375,218.46131,129,250.1066,141,680.02
  少数股东损益(元) -3,323,218.97-1,438,307.68-2,916,698.567,209,858.961,455,466.22--
 扣除非经常性损益后的净利润(元) 112,020,795.2273,320,579.7028,398,397.27187,434,994.68147,582,992.63109,455,940.5865,100,116.12
七、每股收益
 一、基本每股收益(元) 0.630.400.191.421.090.820.54
 二、稀释每股收益(元) 0.630.400.191.421.090.820.54
九、综合收益总额(元) 115,656,533.4875,992,607.4127,455,521.45233,882,579.75172,830,684.68131,129,250.1066,141,680.02
 归属于母公司所有者的综合收益总额(元) 118,979,752.4577,430,915.0930,372,220.01226,672,720.79171,375,218.46131,129,250.1066,141,680.02
 归属于少数股东的综合收益总额(元) -3,323,218.97-1,438,307.68-2,916,698.567,209,858.961,455,466.22--
公告日期 2024-10-302024-08-312024-04-302024-04-232023-10-312023-08-292023-04-18
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院